Tag: cancer
-
Radiation-Antibody Biotech Raises $105M in Venture Funds
A company creating cancer treatments that combine radiation therapy with the targeting of synthetic antibodies is raising $105 million in its second round of venture financing.
-
Immuno-, Chemotherapy Shown to Shrink Pancreatic Cancers
Early results from a clinical trial show a combination of immunotherapy and chemotherapy drugs shrunk tumors in most participants with pancreatic cancer.
-
Genome Editing Biotech Raises $126M in IPO
A biotechnology company developing treatments for disease and enhanced agricultural products with genome editing is raising $126 million in its initial public offering, or IPO, of common stock.
-
Population Data Show Genetics-Health Links
The first batch of data from a large-scale genomic sequencing project in the U.K. shows strong associations between several gene variations and common health conditions.
-
Trial Testing Targeted Solid Tumor Immunotherapy
A clinical trial is underway testing the safety of a cancer therapy that harnesses the immune system, but also works only in the tumor to reduce adverse side effects.
-
Sequencing IDs Pancreatic Cancer Targets
A genomic analysis of tumor samples from patients with pancreatic cancer, a cancer with a typically poor outlook, identified targets for early precision cancer detection and treatments.
-
Blood Test as Good as Biopsy to Detect Cancer Targets
Results of a clinical trial show a commercial blood test works at least as well as tissue biopsies for determining precise genetic mutations causing most lung cancers.
-
Gene Editing Deactivates Cause of T-Cell Side Effects
A biotechnology company developing engineered T-cells as treatments for cancer, used gene editing to deactivate a likely cause of serious adverse effects from its therapies.
-
Organoids Designed for Faster Cancer Diagnostics
A new process grows small samples of tumor tissue in the lab to enable high-speed diagnostics for personalized cancer treatments and drug testing.
-
Start-Up Raises $10.5M for Precision Immunotherapies
A new biotechnology enterprise developing personalized treatments that harness the immune system to treat cancer is raising $10.5 million in its first venture funding round.